May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
/ Positive T-Cells in hIRBP Peptide Induced Eau
Author Affiliations & Notes
  • R.H. Stiemer
    Ophthalmology, Univ. Eye Clinic, Tuebingen, Germany
  • G. Lamont
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • N. Stuebiger
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • I. Crane
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • K. Siepmann
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • J.V. Forrester
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • M. Zierhut
    Ophthalmology, Univ. of Aberdeen, Aberdeen, United Kingdom
  • I. Koetter
    Rheumatology, Univ. of Tuebingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  R.H. Stiemer, None; G. Lamont, None; N. Stuebiger, None; I. Crane, None; K. Siepmann, None; J.V. Forrester, None; M. Zierhut, None; I. Koetter, None.
  • Footnotes
    Support  DFG-grant ZI-350/13
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.H. Stiemer, G. Lamont, N. Stuebiger, I. Crane, K. Siepmann, J.V. Forrester, M. Zierhut, I. Koetter; / Positive T-Cells in hIRBP Peptide Induced Eau . Invest. Ophthalmol. Vis. Sci. 2003;44(13):766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The model of hIRBP (human Interphoreceptor Retinoid Binding Protein) peptide (aa 161-180) induced murine EAU (experimental Autoimmun-uveitis) represents a chronic disease and is used as a model for ocular (BD) Behçet’s disease. We studied the infiltration of TCRγ/δ+ T-cells into the eye during interferon-alpha (IFN-α) treatment in this model. Methods: B10.RIII mice (n=24) were immunized subcutaneously (sc) with 100µg of the hIRBP derived peptide aa 161-180. IFN-α dosage was applied according to our scheme in patients. Twelve animals received daily sc. injected IFN-α (day 1-3: 3x103IU, day 4-10 (18): 6x103 IU). Twelve control mice received no IFN-α. Histological and immunohistochemical analyses of the eyes were carried out on animals sacrificed at day 10 and 18 post-immunization (n=6 for each treatment and time point). Results: Histology at day 10 disclosed 4 of 6 control mice to have severe EAU (grading >3) compared to only 2 of 6 IFN-α treated mice. At day 18 there was histologically little difference between control and IFN-α treated mice. TCRγ/δ+ T-cells infiltrating the retina were detectable in control eyes, a significantly lower amount in IFN-α treated animals. Conclusion: TCRγ/δ+ T-cells have been identified for the first time in the murine EAU model. It has been shown that IFN-α seems to regulate the amount of these T-cells. Interestingly in BD also increased levels of TCRγ/δ+ T-cells are reduced under by IFN-a treatment. It has to be investigated whether these T-cells are antigen specific or exhibit regulatory functions.

Keywords: immunohistochemistry • inflammation • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×